pembrolizumab
merck
['s1512', 'melanoma', 'pembro']
89% of patients with desmoplastic melanoma responded to first-line pembrolizumab, according to results from the s1512 clinical trial. #aacr23 
The mission of the American Association for Cancer Research is to prevent and cure cancer through research, education, communication, and collaboration.